5
Funding Rounds
$76.5m
Money raised
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.
Industries:
Location:
3
Funding Rounds
$14.3m
Money raised
Aria Pharmaceuticals is a first-in-class pharmaceutical discovery and development founded in 2014 by Andrew M. Radin.
Key people:
5
Funding Rounds
$28.9m
Money raised
Antidote.me closes the gap between clinical trials and patients
Location:
Key people:
2
Funding Rounds
$67.5m
Money raised
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases
Industries:
Location:
Key people:
3
Funding Rounds
$37.4m
Money raised
A diagnostics company developing products for diagnosis, prognosis and monitoring of patients with autoimmune rheumatic diseases
Key people:
5
Funding Rounds
$152.0m
Money raised
Synthetic biology company that created novel DNA base pairs and uses them to incorporate novel amino acids into proteins for potential therapeutics in areas of cancer and autoimmune disorders.
Industries:
Location:
Key people:
1
Funding Rounds
$2.0m
Money raised
A life science instrumentation company developing ellipsometry analysis systems for microplates and slide disposables
Industries:
Location:
2
Funding Rounds
$27.0m
Money raised
Vital Therapies is a biotechnology company developing a cell-based therapy to treat acute liver failure.
Industries:
Location:
2
Funding Rounds
$110.0m
Money raised
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
Location:
Key people:
- Jeffrey Greve *******.*****@ensocell.com
4
Funding Rounds
$72.3m
Money raised
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Key people:
- Alex Martin ****.******@abcuro.com
8
Funding Rounds
$84.5m
Money raised
Mogrify is developing tailored cellular conversions that power future cell therapies.
Industries:
Location:
1
Funding Rounds
Biotherapeutics company focused on medicines for chronic inflammation, metabolic disease and autoimmune disease
Industries:
Location:
Key people:
3
Funding Rounds
$138.0m
Money raised
Pandion Therapeutics is a Cambridge, Massachusetts-based company developing modular proteins, antibodies and bispecifics for autoimmune and inflammatory diseases.
2
Funding Rounds
$70.0m
Money raised
Delinia is a biotechnology company that is developing novel therapeutics for treating autoimmune diseases.
Industries:
Key people:
- Jeffrey Greve *******.*****@ensocell.com
12
Funding Rounds
$108.1m
Money raised
Calcimedica is a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC) channels for the treatment of inflammatory and autoimmune disorders and organ transplant rejection.
Industries:
1
Funding Rounds
$44.0m
Money raised
Annexon Biosciences is a South San Francisco, California-based biotechnology company working on discovering and developing therapeutics for neurodegenerative and autoimmune disorders.
Industries:
Key people:
- Arnon Rosenthal **@alector.com
- Ben Barres linkedin
3
Funding Rounds
$210.0m
Money raised
Biotechnology company developing medicines that target allosteric regulatory sites on proteins
Industries:
Location:
Key people:
- Geraldine Harriman *********@hotspotthera.com
- Jonathan Montagu ********@hotspotthera.com
5
Funding Rounds
$4.1m
Money raised
DxTerity Diagnostics is a genomics company developing genomic tests for disease diagnosis and monitoring. Los Angeles-based company.
8
Funding Rounds
$235.2m
Money raised
Crescendo Bioscience is a company that is developing diagnostic tools for autoimmune and inflammatory disease.
4
Funding Rounds
$3.3m
Money raised
Girihlet provides an immune map database. Its platform aims to accelerate immune diseases discovery, monitoring and therapeutic approaches.
Industries:
Location:
Key people:
- Anitha Jayaprakash ******@girihlet.com
- Ravi Sachidanandam ****@girihlet.com
3
Funding Rounds
$13.5m
Money raised
A company developing treatments for cancer and autoimmune diseases
Industries:
Location:
6
Funding Rounds
$474.7m
Money raised
Cell therapy firm specializing in developing treatments using advanced cellular technology.
Industries:
Location:
7
Funding Rounds
$123.8m
Money raised
A company focused on developing immunotherapy treatments for autoimmune disease and cancer
Industries:
Key people:
- Anthony Opipari
- Gary D. Glick ****@odysseytx.com
1
Funding Rounds
$40.6m
Money raised
Therapies designed to achieve long-term disease remission with less frequent doses.
Industries:
Location:
2
Funding Rounds
$32.0m
Money raised
Biond Biologics is an Israel-based immunotherapy company developing treatments for cancer and autoimmune diseases.
Industries:
Key people:
- Ori Shilo linkedin
- Tehila Ben Moshe ******@biondbio.com
5
Funding Rounds
$147.5m
Money raised
A biotechnology company focused on the development of therapeutics for the treatmjent of autoimmune and inflammatory diseases
Industries:
Location:
Key people:
2
Funding Rounds
$62.5m
Money raised
A biopharmaceutical company developing oral small molecule therapies for the treatment of cancer and autoimmune diseases
Industries:
Location:
8
Funding Rounds
$33.4m
Money raised
Innovate Biopharmaceuticals was the name of a clinical stage biotechnology company focused on developing therapeutics for autoimmune and inflammatory diseases. In 2019 Innovate merged with RDD Pharma and renamed the company 9 Meters Biopharma.
Industries:
Location:
1
Funding Rounds
$10.0m
Money raised
A biopharmaceutical company developing small molecule, antiviral drug treatments for the treatment of autoimmune diseases, neuropathic pain, liver diseases and cancer
Industries:
Location:
3
Funding Rounds
$27.0k
Money raised
KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies.
2
Funding Rounds
$59.5m
Money raised
Ignyta is a company that combines medicine and biotechnology for the treatment of cancer and autoimmune diseases.
Industries:
Location:
1
Funding Rounds
$4.0m
Money raised
A biotechnology company focused on developing covalent drugs for the treatment of cancer and other autoimmune diseases
Location:
1
Funding Rounds
$20.0m
Money raised
A company developing immune-based biologics for the treatment of cancer, autoimmunity, transplantation and infectious diseases
Industries:
Location:
3
Funding Rounds
$60.0m
Money raised
A biotechnology company developing therapies and personalized diagnostics for celiac disease
Industries:
Key people:
2
Funding Rounds
$5.1m
Money raised
A company developing compounds for the treatment of autoimmune diseases
Location:
Key people:
1
Funding Rounds
$2.0m
Money raised
A company developing targeted therapeutics for inflammation, autoimmune, oncology, neurodegenerative and central nervous system conditions
Industries:
Location:
Key people:
2
Funding Rounds
$5.5m
Money raised
A biotechnology company developing peptides and antibodies for inflammation and autoimmunity
Industries:
Location:
Key people:
2
Funding Rounds
$7.8m
Money raised
A biopharmaceutical company that develops biologic products to treat lupus and other autoimmune diseases
Industries:
Location:
2
Funding Rounds
$16.8m
Money raised
A drug discovery and development company focused on immunotherapeutic agents to treat cancer, viral infections and autoimmune diseases
Industries:
Location:
1
Funding Rounds
$3.0m
Money raised
A biopharmaceutical company developing small molecule therapeutics for respiratory, inflammatory and autoimmune diseases
Industries:
Location:
Key people:
2
Funding Rounds
$12.0m
Money raised
A biotechnology company developing treat ments for sickle cell disease, cancer, asthma autoimmune and inflammatory diseases
Industries:
Location:
1
Funding Rounds
$1.5m
Money raised
A company developing therapies modulatng T-cell activities to treat autoimmune diseases, diabetes and cancer
Industries:
Location:
1
Funding Rounds
$300.0k
Money raised
A biotechnology company developing immune tolerance therapies products for the treatment of autoimmune diseases in the lung
Industries:
Location:
1
Funding Rounds
$30.0m
Money raised
A biopharmaceutical company that develops drugs for autoimmune and inflammatory diseases
Industries:
2
Funding Rounds
$26.5m
Money raised
A biopharmaceutical company developing treatments and prevention for inflammatory, autoimmune disease and cancer
Industries:
Location:
1
Funding Rounds
$250.0k
Money raised
A company drugs for the treatment of infectious diseases, cancer and autoimmune disorders
Industries:
Location:
1
Funding Rounds
$20.5m
Money raised
A company developing X-nitro compounds for micro treatments for cancer, inflamation, cardiovascular and autoimmune diseases
Industries:
Location:
1
Funding Rounds
$50.0m
Money raised
Syntimmune is a Boston-based company.